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Objective. To determine relative inﬂuences of intrauterine growth restriction (IUGR) and preterm birth on risks of cardiovascular,
renal, or metabolic dysfunction in adolescent children. Study Design. Retrospective cohort study. 71 periadolescent children were
classiﬁed into four groups: premature small for gestational age (SGA), premature appropriate for gestational age (AGA), term
SGA, and term AGA. Outcome Measures. Systolic blood pressure (SBP), augmentation index (Al), glomerular ﬁltration rate (GFR)
following protein load; plasma glucose and serum insulin levels. Results. SGA had higher SBP (average 4.6mmHg) and lower GFR
following protein load (average 28.5mL/min/1.73m2) than AGA. There was no eﬀect of prematurity on SBP (P = .4) or GFR
(P = .9). Both prematurity and SGA were associated with higher AI (average 9.7%) and higher serum insulin levels 2hr after
glucose load (average 15.5mIU/L) than all other groups. Conclusion. IUGR is a more signiﬁcant risk factor than preterm birth for
later systolic hypertension and renal dysfunction. Among children born preterm, those who are also SGA are at increased risk of
arterial stiﬀness and metabolic dysfunction.
1.Introduction
Low birth weight (LBW) is associated with increased risk
of cardiovascular disease (CVD) and the related disorders,
hypertension, stroke, and type-2 diabetes, later in life [1–3].
LBW may be due to preterm birth, poor fetal growth, or a
combination of both. Although their relative importance is
unknown, it is thought that intrauterine growth restriction
(IUGR) is more important than preterm birth per se in the
development of subsequent CVD [4]. With the increasing
survival of extremely preterm infants, this may no longer
be true. Early postnatal growth restriction, common in very
preterm babies, may be as important in development of
later organ dysfunction as IUGR at a similar gestational
age (GA). Furthermore, such infants might have been
exposed to glucocorticoids, either antenatally to accelerate
lung maturation or postnatally to facilitate weaning from
mechanical ventilation. This therapy may also result in later
adverse renal or cardiovascular outcomes [5, 6].
Approximately 7% of babies are born preterm (<37
weeksgestation) [7] with1% being withvery LBW(<1500g)
or very preterm (<29 weeks gestation) [8]. To date, most
long-term followup of very preterm infants have focused
on neurodevelopmental and respiratory complications, with
little attention to cardiovascular, renal, or metabolic out-
comes. Suboptimal intrauterine nutrition may alter fetal
programming during critical periods of growth, caus-
ing permanent changes in metabolism and cardiovascular
or renal structure and function. If abnormal program-
ming occurred postnatally in children born preterm, this
would provide an opportunity for appropriate postnatal
interventions.2 International Journal of Pediatrics
This study was undertaken to determine the relative
inﬂuence of IUGR and preterm birth on subsequent cardio-
vascular,renal,andmetabolicdysfunction.Itwasdesignedto
beclinicallyrelevant,practical,andeasilyachievedinsettings
with limited facilities.
2.MaterialsandMethods
2.1. Setting and Study Cohort. A retrospective cohort study
was conducted at Royal North Shore Hospital (RNSH),
Sydney, Australia. Children who had been born at RNSH
between 1st January 1992 and 31st December 1995 with
birth weight <1500g or GA ≤32 weeks were identiﬁed from
the neonatal intensive care records and studied at present
time (2006–2008) to assess their cardiovascular, renal, and
metabolic function. Recruitment of term subjects, who were
born in 1992–95 and ≥37 weeks gestation, was obtained
by advertisement in local media and through word-of-
mouth by study participants. Subjects were divided into
the following four groups based on gender-speciﬁc, birth
weight percentiles by GA, Australian national data 1991–
94 [9]: preterm and small for gestational age (Prem-SGA),
preterm and appropriate for gestational age (Prem-AGA),
term and SGA (Term-SGA), term and AGA (Term-AGA).
Birth weights were converted to z score by the formula:
(x −mean)/standard deviation.
Our sample size was calculated to detect a 10% diﬀerence
in the primary outcomes with 80% power, for a two-tailed
test and 5% signiﬁcance level. For a 10% reduction in
renal response following protein challenge in children with
standard deviation of 5mL/min [10], 25 were required in
each group. For 10% systolic blood pressure (SBP) increase
in 13-14-year-old children [11], 22 were required. We aimed
to recruit 25 children into each of the four groups.
Ethics approval was granted by the Human Research
Ethics Committee, Northern Sydney Central Coast, NSW
Health as Protocol 0501-028M.
2.2. Outcome Measures. The primary outcomes were as
follows.
(i) Cardiovascular function: SBP, diastolic blood pres-
sure (DBP), and arterial augmentation index stan-
dardized at heart rate 75bpm (AI at 75) [12]a sa
measure of arterial stiﬀness.
(ii) Renal function: urine microscopy, urine protein/
creatinine ratio, serum creatinine, and glomerular
ﬁltration rate (GFR) following oral protein load
adjusted for body surface area (BSA), calculated as
[urine creatinine concentration (mmol/L) × urine
ﬂow (mL/min) × 1.73]/[serum creatinine concentra-
tion (mmol/L) × BSA (m2)], as a measure of renal
functional reserve (RFR).
(iii) Metabolic function: fasting plasma glucose and
serum insulin levels, homeostasis model of assess-
ment for insulin resistance (HOMA-IR), and glucose
and insulin levels following oral glucose load.
2.3. Procedure. Informed consent was obtained from both
mothers and children. Children performed a self-assessment
of puberty stage.
Subjects fasted overnight from 9pm but were allowed
plain water ad libitum. The ﬁrst morning urine specimen
was collected as midstream into boric acid, for urinary
microscopy and measurement of protein/creatinine ratio.
Upon arrival at 0850hr, weight, height, and BP were
measured. Body mass index (BMI) and BSA were calculated.
BP was measured by standard mercury sphygmomanometry
[13], and the average of duplicate readings 5mins apart
recorded. All clinical measurements were performed by one
unblind investigator.
A second urine sample was tested for leucocytes, nitrites,
protein, pH, blood, speciﬁc gravity, ketones, and glucose.
Blood was collected for fasting glucose, insulin, creatinine,
sodium, and potassium levels.
An oral protein load 1g/kg body weight [14], in the form
of Aussie Bodies (Aussie Bodies Pty Ltd.)(drink: skim milk,
AussieBodies Protein Blend[4.8%](calciumcaseinate,whey
protein concentrate), fructose, skim milk powder, emulsiﬁer
(471), stabilisers (401, 407, 412), acidity regulator (331),
ﬂavours, colour (120), sweetener (955), contains milk, soy,
and wheat. Bars: protein blend (31%) (isolated soy protein
(tapioca starch, emulsiﬁer (322), salt), whey protein isolate,
calcium caseinate (soy lecithin)), milk chocolate compound
(20%) (sugar, vegetable fat, milk solids, cocoa, cocoa mass,
emulsiﬁers (492, 322), ﬂavours, salt), glycerine, Aussie
Bodies caramel (10%) (glucose, sweetened condensed milk,
polydextrose, vegetable fat (antioxidant (307)), emulsiﬁer
(471), salt), glucose, peanuts (8%), cocoa (2%), emulsiﬁer
(322), vegetable fat, ﬂavour) was taken over 30–45mins.
Oral glucose load 1.75g/kg body weight to maximum 75g
[15] was taken over 10mins (with Glucaid) after accounting
for the glucose in Aussie Bodies. Subjects were given oral ﬂuid
loading 20mL/kg body weight with water (after accounting
for the ﬂuid from protein and glucose drinks).
Subjects reclined throughout the study period. The right
radial pulse-wave characteristics were assessed by appla-
nation tonometry (SphygmoCor, AtCor Medical, Australia)
[16].
Urine samples were collected 1 and 2hr after protein
load.Volumeandtimewererecorded,andurinarycreatinine
andglucoseweremeasured.Theamountvoidedwasreplaced
with water orally. Further blood sample 2hr after glucose
load was collected for plasma glucose, serum insulin, and
creatinine measurement.
2.4.StatisticalAnalyses. AnalyseswereperformedusingSPSS
v16 for Windows (2007 SPSS Inc., Chicago). The Kruskal-
Wallis test was used to compare continuous variables across
the four groups, and chi-square test for proportions. Sta-
tistical tests were two tailed and statistically signiﬁcant if
P<. 05.
To separate the relative inﬂuences of IUGR and preterm
birth on cardiovascular, renal, and metabolic functions,
multiple linear regression (MLR) analyses were performed
for continuous outcomes. The study factors (size at birth
and preterm birth) were categorized as either SGA or AGAInternational Journal of Pediatrics 3
and preterm (≤32 weeks gestation) or term (≥37 weeks
gestation), to allow easier interpretation and clinical appli-
cation. They were kept in the multivariate model, regardless
of statistical signiﬁcance. Other variables were included in
the baseline multivariate model if the univariate P<. 25.
Variables not known to be confounders or nonsigniﬁcant
(P ≥ .05) in the multivariate model were progressively
eliminated, starting with the least signiﬁcant.
Eﬀect of modiﬁcation on the two study factors was
examined by including an interaction term in the model.
Where the interaction term was signiﬁcant (P<. 05),
further testing was done to determine which subgroups were
signiﬁcantly diﬀerent from each other.
Assumptions of MLR in the ﬁnal model were checked
for normality, linearity, and homoscedasticity by examining
residuals and normal probability plots. Collinearity prob-
lems were checked by stability of baseline models, parameter
estimates, and standard errors.
3. Results
A total of 71 periadolescent children were studied: 14 Prem-
SGA(group1),25Prem-AGA(group2),7Term-SGA(group
3), and 25 Term-AGA (group 4).
Table 1 summarizes the clinical characteristics and mea-
surements, at birth and at the time of study. There were
expected diﬀerences in GA, birth weight, and birth weight
z-score amongst the four groups (P<. 001). There were no
signiﬁcant diﬀerences in gender, age, weight, BMI, SBP, and
DBP at time of study. The Prem-AGA group was taller than
the other 3 groups at the time of study (P = .009), with an
associated increased BSA.
Maternal characteristics of the children, at birth and
time of study, are summarized (Table 2). The highest level
of maternal educational attainment at the time of study is
recorded; all mothers had at least secondary education. Of
the Prem-SGA, 86% gave a history of preeclampsia during
pregnancy compared with 16% Term-AGA (P<. 001).
3.1. Cardiovascular Function. SBP and DBP measurements
are summarized in Figure 1.B yχ2 analysis, there were no
signiﬁcant diﬀerences in SBP or DBP across the 4 groups.
However, in the multivariate analysis of SBP, SGA was a
signiﬁcant risk for increased SBP (P = .002), but preterm
was not (P = .4) after adjusting for current BMI and
DBP(Table 3).Themodelremainedstable,withoutcollinear
problems, and interaction between the study factors was not
signiﬁcant (P = .53). SGA children had an average SBP 4.6
mmHg higher (95% CI: 1.8–7.3mmHg) than those born
AGA (Table 3).
Arterial stiﬀness ﬁndings (AI at 75) are summarized in
Figure 2. There were signiﬁcant diﬀerences across the four
groups (χ2 = 12.21 with 3df, P = .007). In the multivariate
analysis of AI at 75, BSA remained the only signiﬁcant
non-study variable in the model. There was a signiﬁcant
interaction between preterm and size for GA (P = .01). AI
at 75 was signiﬁcantly higher (average: 9.7%, 95% CI: 2.3–
17.1%) in the subgroup Prem-SGA compared with all other
groups (Table 4).
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Figure 1: Box plot of systolic and diastolic blood pressure of
children at the time of study.
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Figure 2: Box plot of augmentation index at heart rate 75bpm of
children at the time of study in 4 groups.
3.2. Renal Function. Results for GFR (measured as true
endogenous creatinine clearance) corrected for BSA, before
a n da f t e rp r o t e i nl o a da r es u m m a r i z e di nFigure 3.T h e r e
were no diﬀerences across the groups in GFR prior to protein
load (χ2 = 7.17 with 3df, P = .07), but results after protein
loading showed a reduction in functional renal reserve in
SGA children (χ2 = 8.27 with 3df, P = .04).
In the multivariate analysis of GFR after protein load,
the only non-study factor variable remaining was GFR pre-
protein (Table 5). Interaction between the study factors was
not signiﬁcant (P = .8). The GFR following protein load
was signiﬁcantly lower in SGA children (P = .01), while
there was no diﬀerence in preterm children (P = .9). For
a SGA child, the average GFR following protein load was
28.5mL/min/1.73m2 lower than that of an AGA child (95%
CI: −50.1 to −6.8mL/min/1.73m2)( Table 5).4 International Journal of Pediatrics
Table 1: Clinical characteristics and measurements of children at birth and at the time of study in 4 groups.
Prem-SGA
N = 14
Prem-AGA
N = 25
Term-SGA
N = 7
Term-AGA
N = 25
P value
∗
At Birth
Gender
Female (%) 7 (50%) 11 (44%) 2 (29%) 12 (48%) .8
Gestational age (wk)
Median 31 30 39 40 <.001
IQR 28.8–31.0 27.5–31.0 38.0–40.0 38.5–41.0
Birth weight (g)
Median 980 1635 2750 3302 <.001
IQR 768–1038 991–1850 2430–2870 3105–3690
Birth weight z score
Median −1.59 0.30 −1.58 −0.30 <.001
IQR −2.20–1.49 −0.27–0.85 −2.35–1.41 −0.62–0.33
Time of Study
Age (yr)
Median 13.5 14.1 13.6 13.6 .06
IQR 12.48–13.97 13.66–15.03 12.35–14.83 12.54–14.78
Weight (kg)
Median 44.3 56.0 51.2 47.2 .06
IQR 31.63–52.13 45.50–60.15 40.00–56.50 41.60–53.25
Height (cm)
Median 153.9 164.8 156.9 156.6 .009
IQR 146.00–160.98 157.25–169.65 149.50–167.00 151.65–162.55
BMI (kg/m2)
Median 17.74 19.74 19.03 18.27 .4
IQR 15.33–21.06 17.98–21.27 17.45–21.80 17.38–20.42
BSA (m2)
Median 1.40 1.62 1.52 1.46 .03
IQR 1.15–1.49 1.43–1.72 1.29–1.59 1.36–1.54
SBP (mmHg)
Median 107 101 105 103 .6
IQR 90.0–114.5 95.0–107.5 95.0–110.0 103.0–105.0
DBP (mmHg)
Median 65 61 65 60 .7
IQR 58.0–70.5 60.0–70.0 55.0–66.0 60.0–65.0
Abbreviations: BSA: body surface area; BMI: body mass index; DBP: diastolic blood pressure; IQR: interquartile range; SBP: systolic blood pressure;P r e m -
AGA: preterm appropriate for gestational age; Prem-SGA: preterm small for gestational age; Term-AGA: term appropriate for gestational age; Term-SGA:
term small for gestational age.
∗For comparisons across 4 groups, the Kruskal-Wallis test was used for continuous variables and the Pearson chi-square test for discrete variables.
3.3. Metabolic Function. There was no signiﬁcant diﬀerence
across the four groups for HOMA-IR (χ2 = 2.58 with 3df,
P = .5), glucose level either at fasting (χ2 = 2.81 with
3df, P = .4) or after glucose load (χ2 = 5.72 with 3df,
P = .13), and insulin level either at fasting (χ2 = 2.36 with
3df, P = .5) or after glucose load (χ2 = 1.77 with 3df,
P = .6).
In the multivariate analysis, neither being preterm (P =
.4) nor SGA (P = .6) was signiﬁcant for HOMA-IR. For 2-
hr glucose level following glucose load, preterm birth was
signiﬁcant (P = .03) while being SGA was not (P = .9). In
preterm children, the mean 2-hr glucose level (3.9mmol/L)
following glucose load was 0.25mmol/L lower (95% CI:
−0.48 to −0.02mmol/L) than that of term children, a
statistically but not clinically signiﬁcant diﬀerence. However,
being both preterm and SGA was signiﬁcantly associated
with increased 2-hr insulin level following glucose load; the
average level (35.6mIU/L) was 15.5mIU/L higher (95% CI:
5.6–25.5mIU/L, P = .003) compared with all other groups
(Table 6).International Journal of Pediatrics 5
Table 2: Maternal characteristics of children at birth and at the time of study in 4 groups.
Prem-SGA
N = 14
Prem-AGA
N = 25
Term-SGA
N = 7
Term-AGA
N = 25
P value
∗∗
Preeclampsia in index pregnancy∗ 12 (86%) 3 (12%) 2 (29%) 4 (16%) <.001
Maternal gestational diabetes
∗ 000 1 ( 4 % ) .6
Maternal education
#
Secondary 5 (36%) 9 (36%) 2 (29%) 1 (4%) .04
Tertiary 9 (64%) 16 (64%) 5 (71%) 24 (96%)
Maternal smoking
# 1 (7%) 2 (8%) 1 (14%) 1 (4%) .8
∗At Birth.
#At the Time of Study.
∗∗For comparisons between 4 groups, chi-square tests were used.
Table 3: Coeﬃcients for dependent variable: systolic blood pressure.
Model Coeﬀ.S E tP 95% CI
Lower Upper
(Constant) 9.72 7.14 1.36 .178 −4.55 23.98
Preterm
∗ −1.01 1.27 −0.79 .431 −3.55 1.53
Birth Size
∗ 4.57 1.39 3.30 .002 1.80 7.34
Current BMI
# 1.11 0.24 4.69 <.001 0.64 1.58
DBP
# 1.12 0.11 10.42 <.001 0.90 1.33
∗Binary. #Continuous.
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Figure 3: Box plot of glomerular ﬁltration rate, corrected for body
surface area before and after protein challenge of children in 4
groups.
4. Discussion
Inthiscohortofperiadolescentchildren,wehaveshownsub-
tle but deﬁnite and diﬀerent long-term eﬀects of both IUGR
and preterm. These eﬀects were evident in cardiovascular,
renal, and metabolic function.
4.1. Cardiovascular Function: Blood Pressure. Our result on
the risk of increased SBP in children born with IUGR is
consistent with some [3, 17, 18]b u tn o ta l l[ 19–21]p r e v i o u s
studies. In some of the latter publications, it is not possible
to separate the eﬀects of preterm and IUGR, because of
noncomparability of their study groups [19, 20]. Johansson
et al. [21] reported an increased risk of high SBP in SGA
born preterm amongst young adult men. These results are
compatible with ours. BP is “tracked” across age [22], and
any eﬀect of low birth weight on BP will be magniﬁed
in an older cohort study [23]. In addition, young adult
men are generally at greater risk of cardiovascular disease
than young women [24]. Changes could be more subtle
in our subjects because they are younger. Huxley et al.
[25] suggested that the inverse relationship between birth
weight and SBP may be spurious, because of adjustment
for current weight by investigators. However, a more recent
meta-analysis by Gamborg et al. [17] concluded that the
relationship was present regardless of current BMI—this is
consistent with our results. Although the average diﬀerence
i nS B Pb e t w e e nS G Aa n dA G Ag r o u p s( 3 . 7 m m H g )w a s
reduced without adjustment for current BMI (4.6mmHg),
it was still signiﬁcant (P = .02).
The subjects were 12–15 years old when this study was
conducted. Adolescents experience complex physiological
changes which may confound/mask an association between
birth weight and SBP [26]. Despite this, we found an inverse
association between birth weight and SBP, consistent with
other studies [27, 28].
4.2. Cardiovascular Function: Arterial Stiﬀness (AI at 75).
Our ﬁnding of increased arterial stiﬀness in children born
both preterm and SGA is consistent with the ﬁndings of
Cheung et al. [29] and Singhal et al. [30]. Several studies
have failed to distinguish between low birth weight related6 International Journal of Pediatrics
Table 4: Coeﬃcients of augmentation index at heart rate 75bpm for subgroup Prem-SGA.
Model Coeﬀ SE tP 95% CI
Lower Upper
(Constant) 36.82 11.25 3.27 .002 14.36 59.27
Prem SGA 9.70 3.70 2.62 .011 2.31 17.09
BSA (DuBois)
∗ −25.78 7.39 −3.49 .001 −40.53 −11.02
∗Body Surface area (using Du Bois method).
Table 5: Coeﬃcients for dependent variable: glomerular ﬁltration rate following protein load, corrected for body surface area.
Model Coeﬀ SE tP 95% CI
Lower Upper
(Constant) 63.14 23.65 2.67 .010 15.92 110.35
Preterm −0.79 9.83 −0.08 .936 −20.40 18.825
Birth Size −28.48 10.84 −2.63 .011 −50.12 −6.835
GFR1Corr
∗ 0.68 0.17 4.07 <.001 0.35 1.01
∗GFR before protein load.
to preterm and that due speciﬁcally to IUGR [31–33]. This
makes comparisons to our ﬁndings impossible. A recent
systematic review [34] concluded that poor fetal growth
and preterm birth produce diﬀerent patterns of altered
vascular system development, with diﬀerent implications for
cardiovascular health in adult life.
The mechanism whereby discordance between birth
weight and GA leads to an increase in arterial stiﬀness in
preterm children remains unclear. The reported impairment
of endothelial function in preterm and SGA individuals [30]
suggests functional alteration of arterial tone contributing
to the increase in systemic arterial stiﬀness. While the
underlying cause is yet to be revealed, whether epigenetic
modiﬁcation [35], accelerated telomere ablation [36], or
othermechanisms,itappearsthatalteredvascularphysiology
associated with LBW is largely irreversible. Children born
SGA and/or very preterm should therefore be followed up
for future cardiovascular risk.
4.3. Renal Function: Renal Functional Reserve (RFR). As we
did not expect major overt renal functional impairment,
GFR under protein-loaded conditions was measured to
detect subtle changes in RFR. It is clear from our results
that IUGR was associated with reduced RFR (P = .01)
while preterm per se was not (P = .9). This may lead
to earlier appearance of the reduced GFR encountered in
disorders such as hypertension, type-2 diabetes, and the
metabolic syndrome. These ﬁndings are consistent with
previousstudiesdescribingassociationsofLBWwithseverity
of expression and progression of kidney disease from various
causes [37–39] and indicate real value for early screening in
these individuals.
Long-term data on renal function in subjects born very
preterm are few. Two studies compared renal function in
preterm subjects or those with IUGR with full-term subjects
[40, 41]. In the ﬁrst, reduced creatinine clearances were
found in 40 school-age children born preterm compared
with 43 controls of similar age (but no diﬀerences were
detected when Preterm-SGA and AGA groups were com-
pared with each other) [40]. In the second, examining young
adult women, the Term-SGA and preterm groups showed
a nonsigniﬁcant reduction in GFR, but no Preterm-SGA
subjects were included [41]. Neither study measured the
eﬀect of protein loading on renal function and therefore did
not assess RFR.
Ar e c e n ts t u d y[ 42] investigating 23 Preterm-SGA, 29
Preterm-AGA (<32 weeks), and 30 Term-AGA controls, at
a mean age of 20.7 years showed that Preterm-SGA subjects
hadalowerbaselineGFR(usinginulinclearance)thaneither
Preterm-AGA or control. Unfortunately, there was no Term-
SGA group included, making it diﬃcult to separate the
eﬀects of IUGR and preterm. Stimulation by high-protein
meals increased GFR in all three groups. Surprisingly (given
that baseline GFR was lower in the Preterm-SGA group),
following adjustment for current BSA, stimulated GFR was
not signiﬁcantly diﬀerent among the groups.
Brenner and colleagues [43, 44] hypothesized that IUGR
may cause a low nephron number, thus predisposing to later
hypertension and renal disease. Subsequent studies showed
that LBW and IUGR were associated with mild to moderate
elevations of BP [45], reduced numbers of compensatory
hypertrophied glomeruli [46–48], lower GFR, and higher
urine albumin-to-creatinine ratio [37, 49]. Preterm infants
have fewer glomeruli than infants born at term [50].
Therefore, both IUGR and preterm may lead to reduced
number of nephrons.
Although preterm birth was not found to be an inde-
pendent risk factor for renal dysfunction in our study, larger
studies should be undertaken and adults with preterm births
f o l l o w e d - u pa sr e n a lf u n c t i o nd e c r e a s e sw i t ha g e .
4.4. Metabolic Function. Using HOMA-IR [51]a sa no u t -
come measure of insulin resistance, neither being born
preterm(P = .4)norSGA(P = .6)wassigniﬁcantriskfactor.International Journal of Pediatrics 7
Table 6: Coeﬃcients for dependent variable: insulin level after 2hrs glucose challenge for Prem-SGA.
Model Coeﬀ SE tP 95% CI
Lower Upper
(Constant) −573.81 155.74 −3.69 <.001 −884.92 −262.69
Prem SGA 15.541 5.00 3.11 .003 5.56 25.53
Ht 3.86 1.01 3.81 <.001 1.84 5.88
Wt −6.54 1.69 −3.87 <.001 −9.92 −3.16
Current BMI 17.08 4.20 4.07 <.001 8.69 25.46
F Insulin
∗ 1.84 0.42 4.40 <.001 1.00 2.67
Mat Ed
∗∗ −11.93 4.38 −2.73 .008 −20.67 −3.18
∗Fasting Insulin.
∗∗Maternal Education (2 categories: secondary, tertiary).
Similarly, fasting glucose and fasting insulin levels were not
signiﬁcantly diﬀerent across the four groups.
This ﬁnding is consistent with other studies [30, 52]
which found fasting glucose and insulin levels comparable
between Preterm-SGA and AGA children [52].
With glucose levels 2hr after glucose load as outcome
measure, being preterm was signiﬁcant (P = .03) while
being SGA was not (P = .9). In preterm children, the
mean 2-hr glucose level was 0.25mmol/L lower (95% CI
−0.48 to −.02mmol/L) than that in term children. Although
statistically signiﬁcant, such a diﬀerence is not clinically
signiﬁcant. This is in contrast to Hovi et al. [53]w h o
reported signiﬁcantly higher 2hr glucose concentrations in
preterm LBW young adults compared with term controls.
The diﬀerence in ﬁndings could be due to an older age group
studied (range: 18–27 years), in contrast to our study mean
age of 13.8 years (range: 11.3–15.6 years). Similar to our
study, the diﬀerences between SGA and AGA in the preterm
groups were not signiﬁcant.
In children born both preterm and SGA, the average 2-hr
insulin level following glucose load was 15.5mIU/L higher
(95% CI: 5.6–25.5mIU/L) than in all other groups. This
suggests that poor fetal growth and preterm birth are both
signiﬁcant risk factors for diabetes in later life. The results
support the previously reported inverse association between
birth weight and later development of diabetes [2, 54–58]
andprovideevidenceforaninteractionbetweenpretermand
poor fetal growth. Hofman et al. [59] found that children
born preterm, whether AGA or SGA, had reduced insulin
sensitivity similar to that seen in term-SGA. Hovi et al.
[53] also reported that young adults born preterm with
very LBW (<1500g) had higher 2hr glucose concentration
and more insulin resistance than those born at term. A
recent study has suggested that the association between
LBW and risk for diabetes is mediated through poor fetal
growth and preterm birth [60]. Another study has shown
an inverse relationship between birth weight and fasting
plasma glucose, following glucose load and hemoglobin A1C
[61], but information regarding GA and preterm birth was
not given. A recent systematic review concluded that birth
weight was inversely related to a risk of type-2 diabetes
[62].
5. GeneralDiscussion
The ﬁndings presented here support the hypothesis that
children born with IUGR are at risk of later systolic hyper-
tension, cardiovascular, renal, and metabolic dysfunction.
Among children born preterm, only those with IUGR appear
to be at increased risk of arterial stiﬀness and metabolic
dysfunction. It has been recognised for over 30 years that
maternal undernutrition during pregnancy results in infants
of LBW and that these infants exhibit in late adult life an
increased risk of cardiovascular morbidity, renal disease and
typeIIdiabetesmellitus[63],allassociatedwithanincreased
rate of preterm death. More recent publications have shown
thattheincreaseinthesedisordersisalreadypresentinyoung
adults and is found to be not only consequent on maternal
under-nutrition but also more speciﬁcally on fetal growth
restriction from a variety of causes [64, 65]. In the current
study, evidence is presented that subtle but signiﬁcant
diﬀerences in cardiovascular function, renal function, and
glucose metabolism are detectable in LBW infants even
before adult life. In addition, it appears that preterm birth
and IUGR expose infants to separate and probably additive
risks of these adverse outcomes.
The limitations of this study must be acknowledged.
The main problem encountered was recruiting children for
a study involving venepuncture. Recruitment of children is
more diﬃcult and challenging compared with adults [66,
67]. The period of recruitment was limited, to reduce the
potential confounding impact of developments in neonatal
care. Some of the nonsigniﬁcant results may be due to
the sample size being too small to detect diﬀerences. Pre-
eclampsia is frequently associated with IUGR. It is also a
signiﬁcant risk factor for renal dysfunction and associated
with metabolic syndrome—larger numbers may expose a
relationship. Nevertheless, several signiﬁcant results despite
thesamplesizesuggestthatthediﬀerencesarerelativelylarge.
As puberty aﬀects cardiovascular, renal, and metabolic
functions, another limitation of the study is that pubertal
stage was not formally assessed. As there were no signiﬁcant
age diﬀerences across the groups, and age was further tested
as a potential confounder in regression analyses, one would
expect the eﬀects of puberty to be equal across all groups8 International Journal of Pediatrics
despite the variable onset of puberty. Ideally, children would
be followed after puberty, as young adults.
The ﬁndings of this study indicate pressing reasons
for supervision of the health and nutrition of all LBW
infants—at least into adult life—regardless of the cause
of their LBW. Since the advent of specialised neonatal
intensive care, the survival of extremely preterm and/or
growth-restricted babies has increased signiﬁcantly. Eﬀorts
to identify individuals at increased disease risk well before
any clinical manifestation provide a window of time that
may allow delay or prevention of overt disease. Clearly,
screening of this population for abnormalities will be most
achievable if the measurements are clinically and technically
simple, relatively noninvasive, and inexpensive. All of the
measurements made in this study meet these criteria. They
can be performed in a community setting and require only
basic diagnostic laboratory facilities.
That such signiﬁcant ﬁndings were evident in a relatively
small cohort study provides strong support for a larger
community-based examination of blood pressure, arterial
stiﬀness, renal functional reserve, and glucose tolerance. The
relevant preventive measures and interventions which can be
achievedpostnatallywillneedtobeassessedandevaluatedin
further well-designed studies.
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